Skip to content
  • Tuesday, 27 October 2026
  • 11:30 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Canada’s Drug Agency Data Reveals Evolving Landscape of Drug Approvals and Reimbursement
Pharmaceutical R&D

Canada’s Drug Agency Data Reveals Evolving Landscape of Drug Approvals and Reimbursement

Teuku Ryan Jun 14, 2026 0

In April 2026, Canada’s Drug Agency (CDA) unveiled an expanded dataset, offering a comprehensive look at the trends and intricacies…

Read More
Pharmaceutical R&D

New Qulipta Study Data Bolsters Case Against Restrictive European Reimbursement Policies

Teuku Ryan Apr 25, 2026 0

New clinical trial results presented by AbbVie are poised to significantly influence the landscape of migraine prevention in Europe, providing…

Read More
Clinical Diagnostics & Pathology

Executive War College 2026 Speaker Spotlight Illuminates Path for Labs Navigating Reimbursement Pressures and Regulatory Shifts

Reynand Amr Wu Mar 18, 2026 0

The 2026 Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management, scheduled for April 28-29 in New Orleans, is…

Read More
Silent Reduction: Understanding, Managing, and Preventing Osteopenia Before It ProgressesAAPS PharmSci 360 Offers Fresh Insights for Industry ScientistsBayer Acquires Perfuse Therapeutics for Up to $2.45 Billion to Bolster Ophthalmology Pipeline with Novel Endothelin Receptor AntagonistMolecular Switch FLI-1 Identified as Key Driver for Blood Stem Cell Regeneration and Enhanced Bone Marrow Transplants
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ